Cargando…
Metronomic combination chemotherapy using everolimus and etoposide for the treatment of non‐Hodgkin lymphoma
Patients with Non‐Hodgkin lymphoma (NHL) treated by conventional chemotherapeutic drugs usually require a long recovery period. However, metronomic combination chemotherapy (MCC) enhances therapeutic efficacy and decreases side effects in the treatment of NHL. In this study, we tested and compared t...
Autores principales: | Wu, Ke, Sun, Xiao‐Qing, Wang, Cai‐Qin, Gao, Tian‐Xiao, Sun, Peng, Wang, Yu, Jiang, Wen‐Qi, Li, Zhi‐Ming, Huang, Jia‐Jia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712471/ https://www.ncbi.nlm.nih.gov/pubmed/31218841 http://dx.doi.org/10.1002/cam4.2364 |
Ejemplares similares
-
Efficacy and safety of oral metronomic etoposide in adult patients with metastatic osteosarcoma
por: Perret, Audrey, et al.
Publicado: (2020) -
Comparison of Ifosfamide, Carboplatin and Etoposide versus Etoposide, Steroid, and Cytarabine Cisplatin as Salvage Chemotherapy in Patients with Refractory or Relapsed Hodgkin's lymphoma
por: Mehrzad, Valiollah, et al.
Publicado: (2017) -
Combination chemotherapy consisting of irinotecan, etoposide, and carboplatin for refractory or relapsed neuroblastoma
por: Imaya, Masayuki, et al.
Publicado: (2022) -
Low‐dose metronomic chemotherapy improves tumor control in nasopharyngeal carcinoma
por: Chen, Yu‐Pei, et al.
Publicado: (2022) -
Etoposide and adriamycin containing combination chemotherapy (HOPE-Bleo) for relapsed Hodgkin's disease.
por: Perren, T. J., et al.
Publicado: (1990)